Arbitral Digest

Matter

Bioalliance Pharma v Spepharm Holding BV and Spebio BV

French proceedings concerning an intermediate arbitral award in the BioAlliance Pharma dispute and the requirement to challenge it through an action to set aside.

  • Setting aside arbitral awards
Industry type
Manufacturing

Procedural record

  1. 8 April 2010Arbitration

    8 April 2010Arbitration

    Intermediate arbitral award

    Participants

    Bioalliance Pharma
    Spepharm Holding B.V.
    Spebio B.V.

    1 year and 27 days later · 392 days

  2. 5 May 2011France

    5 May 2011France

    Judgment of the Paris Court of Appeal dated 5 May 2011

    Paris Court of Appeal

    Decision summary
    The Paris Court of Appeal refused to join Bioalliance Pharma's appeal-nullity to its action to set aside the intermediate arbitral sentence, declared the appeal-nullity inadmissible, and ordered Bioalliance Pharma to pay costs and specified sums to Spepharm Holding B.V. and Spebio B.V.

    Participants

    Bioalliance Pharma
    Spepharm Holding B.V.
    Spebio B.V.
    Paris Court of Appeal

    2 years, 6 months and 1 day later · 916 days

  3. 6 November 2013France

    6 November 2013France

    Judgment of the French Court of Cassation, First Civil Chamber dated 6 November 2013

    French Court of Cassation, First Civil Chamber

    Decision summary
    The Court of Cassation dismissed Bioalliance Pharma's appeal. It held that an exequatur order for an international arbitral sentence may be challenged through the action to set aside the sentence, so an exceptional appeal-nullity was unavailable.

    Participants

    Bioalliance Pharma
    Representative
    Me Bouthors (For: Bioalliance Pharma)
    Spepharm Holding B.V.
    Spebio B.V.
    French Court of Cassation, First Civil Chamber

    Authorities cited

    2
    • French Code of Civil Procedure, Article 1504(2)
      statute
    • Convention for the Protection of Human Rights and Fundamental Freedoms, Articles 6 and 13
      treaty

Matter record

Report a correction

Bioalliance Pharma v Spepharm Holding BV and Spebio BV · Matter